RedHill Biopharma Announces Fifth U.S. Patent Covering TALICIA® for H. pylori Infection
17 janv. 2019 08h00 HE
|
RedHill Biopharma Ltd.
Notice of Allowance received and, once granted, the new U.S. patent is expected to be valid until 2034NDA submission is expected in H1/2019, with eligibility for 6-month priority review; Subject to...
Phunware Announces Patent for Enterprise Branded Application Frameworks for Mobile and Other Environments
16 janv. 2019 08h30 HE
|
Phunware, Inc.
AUSTIN, Texas, Jan. 16, 2019 (GLOBE NEWSWIRE) -- Today Phunware, Inc. (NASDAQ: PHUN), a fully integrated enterprise cloud platform for mobile that provides companies the products, solutions, data...
Welldoc Achieves Significant Digital Health Milestone by Securing Its 10th Patent for Its BlueStar® Digital Therapeutic
07 janv. 2019 09h08 HE
|
WellDoc Inc.
COLUMBIA, Md., Jan. 07, 2019 (GLOBE NEWSWIRE) -- Welldoc, a leading digital health company, announced today that it has secured a technology patent (based on U.S. Patent Application No. 15/923,010)...
NaturalShrimp, Inc. Receives U.S. Patent for System it Developed to Grow Gourmet-Grade Shrimp in Enclosed, Salt-Water System
03 janv. 2019 07h30 HE
|
NaturalShrimp, Inc.
DALLAS, TX, Jan. 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- NaturalShrimp, Inc. (OTCQB: SHMP) is pleased to announce that NaturalShrimp and F&T Water Solutions, LLC have received U.S....
The Patent Trial and Appeal Board Gives Voip-Pal Another Significant Victory by Declining to Impose Apple’s Requested Sanctions Against Them
24 déc. 2018 05h00 HE
|
Voip-Pal.Com Inc.
BELLEVUE, Wash., Dec. 24, 2018 (GLOBE NEWSWIRE) -- Voip-Pal.com Inc. (“Voip-Pal”, “Company”) (OTCQB: VPLM) is pleased to report the Patent Trial and Appeal Board (“PTAB”) has decided Apple’s Motion...
Translate Bio Expands Patent Portfolio with Newly Issued U.S. Patent Relating to Its Messenger RNA (mRNA) Therapeutics Platform (MRT™)
04 déc. 2018 09h15 HE
|
Translate Bio, Inc.
LEXINGTON, Mass., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative...
UPDATE - Voip-Pal Provides Status Update of its Patent Infringement Lawsuits
29 nov. 2018 06h29 HE
|
Voip-Pal.Com Inc.
BELLEVUE, Wash., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Voip-Pal.com Inc. (“Voip-Pal”, “Company”) (OTCQB: VPLM) provides the following updates regarding the Company’s patent infringement lawsuits against...
Voip-Pal Provides Status Update of its Patent Infringement Lawsuits
29 nov. 2018 05h00 HE
|
Voip-Pal.Com Inc.
BELLEVUE, Wash., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Voip-Pal.com Inc. (“Voip-Pal”, “Company”) (OTCQB: VPLM) provides the following updates regarding the Company’s patent infringement lawsuits against...
PCT LTD Announces Completion of Major Commercialization Milestones and Promotion of Jody Read to CEO Position
08 nov. 2018 17h14 HE
|
PCT Ltd.
LITTLE RIVER, S.C., Nov. 08, 2018 (GLOBE NEWSWIRE) -- PCT LTD (OTC Pink: PCTL), a leader in environmentally safe, non-toxic, antimicrobial solutions for global sustainability, has reached...
Cannabis Science Confirms Receipt of Issued US Patent Number 9,763,991 For Compositions of Cannabinol (CBN) for Treatment of Various Neurobehavioral Disorders, Sleep Deprivation (Insomnia), Anxiety Disorders (ADHD), and (PTSD)
29 oct. 2018 09h01 HE
|
Cannabis Science, Inc.
IRVINE, CA, Oct. 29, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to...